Skip to main content
UniHealth

Doctor search

Sumit A Shah, MD

Internal Medicine · Stanford

NPI 1942529227

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
17
3 carriers
Office
1

Offices

1 location · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.

Plans that list them

17 plans · 3 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Shah’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

17 of 17 plans

Plans whose provider directory lists this clinician
Alignment Health BreathEasy (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Clarity (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Harmony (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes CalPlus (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes Care (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Heart & Diabetes Choice (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Honor+ Plan (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health My Choice CalCare (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Silicon (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health smartHMO (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health the ONE (HMO)Alignment Health PlanListedOct 3, 2026
SCAN Balance (HMO C-SNP)SCAN Health PlanListedOct 3, 2026
SCAN Classic (HMO)SCAN Health PlanListedOct 3, 2026
SCAN MyChoice (HMO)SCAN Health PlanListedOct 3, 2026
SCAN Strive (HMO C-SNP)SCAN Health PlanListedOct 3, 2026
DualConnect (HMO D-SNP)Santa Clara Family Health PlanListedSep 1, 2026

California Medical Board record

Licence A120808 · Current

Licensed to practise in California · since 2012 · expires 2028-04-30 · Stanford University School of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
76.5 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Hospitals they work in

2 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
  • Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend it
    Overall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%
See every measure and the patient survey for Stanford Health Care Tri-Valley

Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care Tri-Valley
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.178BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.237BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.79 (0 to 1.73) · 1,041 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.79 (0.5 to 1.08)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths145.81 (96.5 to 195.12) · 72 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.9 · 55 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths8.6 · 92 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths12.5 · 96 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths9.5 · 395 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 391 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths10.1 · 162 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3 · 1,736 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.16 (0 to 0.37) · 4,425 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.22 (0.02 to 0.41) · 4,771 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.45 (1.46 to 5.44) · 1,403 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.5 (0.05 to 2.94) · 645 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths1.81 (0.38 to 3.24) · 1,279 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths8.53 (3.2 to 13.85) · 639 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.15 (1.89 to 8.41) · 648 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.61 (0.14 to 3.07) · 370 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.16 (0 to 0.83) · 4,160 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4 · 74 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.369No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections1.112No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits13.1 · 110 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.1 · 437 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits-5.8 · 94 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-19.3 · 456 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits-0.3 · 402 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits15.8 · 358 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits6.8 (4.7 to 9.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits10.1 (7.5 to 13.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.3 · 80 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10.9 · 46 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.3 · 92 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.4 (9.6 to 16.2) · 1,532 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1 (0.8 to 1.2) · 929 casesNo differentJan 2024 – Dec 2024

What patients said (1,268 patients answered, 26% of those asked)

Patient survey stars by topic at Stanford Health Care Tri-Valley
Cleanliness3
Nurse communication3
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating3
Quietness2
Recommend hospital4
Share of patients giving the best answer at Stanford Health Care Tri-Valley
Room was "always" clean65%
Nurses "always" communicated well77%
Doctors "always" communicated well79%
Staff "always" explained58%
Yes, staff "did" give patients this information88%
Yes, staff "did" give patients information about help after discharge88%
Doctors "always" explained things so they could understand74%
Doctors "always" listened carefully78%
Doctors "always" treated them with courtesy and respect86%
Patients who gave a rating of "9" or "10" (high)70%
Staff "always" explained new medications72%
Nurses "always" explained things so they could understand73%
Nurses "always" listened carefully74%
Nurses "always" treated them with courtesy and respect84%
"Always" quiet at night42%
"YES", patients would definitely recommend the hospital74%
Staff "always" explained possible side effects44%
Yes, staff "did" give patients information about possible symptoms89%

Original Medicare doctor bills

$172,535

Medicare paid this office $172,535 for 402 people. Most of that is long return visits and Botox.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Long return visit (40+ min)221$89,718$160
Return visit (30+ min)146$27,927$107
Long return visit (40+ min)57$14,033$122
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's269$9,033$15
New patient visit (60+ min)45$8,637$192
See all 11 services
Every Original Medicare service billed
Long return visit (40+ min)221$89,718$160
Return visit (30+ min)146$27,927$107
Long return visit (40+ min)57$14,033$122
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's269$9,033$15
New patient visit (60+ min)45$8,637$192
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes24$6,232$106
Initial hospital care with moderate level of medical decision making at least 75 minutes35$5,238$150
New patient visit (60+ min)30$4,735$158
Return visit (30+ min)14$1,628$74
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's58$1,618$15
Hospital discharge day management, more than 30 minutes11$1,154$105

Who their Medicare patients are

402 Original Medicare patients in 2024. Average age 76 · Under 65 5% · 85 and older 13% · Women 11% · Also on Medicaid 19% · Health risk score 2.19. Above the middle of the specialty; the typical internal medicine clinician is at 1.76.

Conditions among them: High blood pressure 75% · Cancer 75% · Chronic kidney disease 35% · Coronary heart disease 33% · Diabetes 31% · Atrial fibrillation 22% · Heart failure 17% · Depression 14% · COPD 10% · Stroke 9% · Dementia 7%.

The office billed $882,535, Medicare allowed $228,641 and paid $172,535; for 1,877 services of 15 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
20244021,877762.19$882,535$172,535
20233821,215751.98$750,364$140,830
20223521,149752.03$773,636$131,481
20213241,157752.18$724,868$132,554
20203351,149742.11$531,999$107,777
2019289965752.30$181,517$88,421
2018161561751.82$95,967$55,600
201782204741.80$56,268$22,489

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 10 services

Original Medicare services billed in 2023
Long return visit (40+ min)185$58,798$125
Long return visit (40+ min)80$27,465$122
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes40$16,565$110
New patient visit (60+ min)72$10,989$153
Return visit (30+ min)74$9,884$82
Return visit (30+ min)43$5,302$75
Initial hospital care with moderate level of medical decision making at least 75 minutes30$5,278$160
Hospital discharge day management, more than 30 minutes17$1,928$107
New patient visit (60+ min)11$1,503$137
Telephone medical discussion with physician, 21-30 minutes11$1,023$73

2022: 9 services

Original Medicare services billed in 2022
Long return visit (40+ min)180$55,013$128
Long return visit (40+ min)80$20,791$123
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes34$14,312$94
Return visit (30+ min)91$13,001$81
New patient visit (60+ min)64$10,386$162
Initial hospital care with moderate level of medical decision making at least 75 minutes27$4,937$183
Return visit (30+ min)42$4,935$77
New patient visit (60+ min)19$2,892$152
Hospital discharge day management, more than 30 minutes21$2,068$98

2021: 10 services

Original Medicare services billed in 2021
Long return visit (40+ min)126$45,174$131
Return visit (30+ min)100$18,663$88
Long return visit (40+ min)64$18,100$127
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes40$12,792$95
New patient visit (60+ min)66$11,161$169
Return visit (30+ min)55$8,662$79
Initial hospital care with moderate level of medical decision making at least 75 minutes35$7,046$185
Hospital discharge day management, more than 30 minutes32$3,227$101
New patient visit (60+ min)16$2,880$180
Telephone medical discussion with physician, 21-30 minutes13$1,507$79

2020: 10 services

Original Medicare services billed in 2020
Long return visit (40+ min)82$20,110$99
Return visit (30+ min)116$18,029$68
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes51$14,329$97
Return visit (30+ min)81$12,865$67
New patient visit (60+ min)79$11,731$148
Initial hospital care with moderate level of medical decision making at least 75 minutes52$10,409$189
Long return visit (40+ min)53$10,056$95
Hospital discharge day management, more than 30 minutes42$4,387$100
New patient visit (60+ min)24$3,500$146
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes12$1,078$67

2019: 10 services

Original Medicare services billed in 2019
Long return visit (40+ min)108$24,658$94
Long return visit (40+ min)54$12,464$94
New patient visit (60+ min)82$11,641$142
Return visit (30+ min)84$10,725$65
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes29$9,203$93
Return visit (30+ min)50$8,559$66
Initial hospital care with moderate level of medical decision making at least 75 minutes22$3,979$181
New patient visit (60+ min)20$2,857$143
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes15$1,366$65
Hospital discharge day management, more than 30 minutes12$1,173$98

2018: 7 services

Original Medicare services billed in 2018
Long return visit (40+ min)58$16,790$95
Long return visit (40+ min)40$12,847$95
New patient visit (60+ min)66$9,731$147
Return visit (30+ min)38$3,603$67
Return visit (30+ min)28$3,532$71
New patient visit (60+ min)22$2,923$133
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes11$2,902$94

2017: 6 services

Original Medicare services billed in 2017
Long return visit (40+ min)20$4,882$100
New patient visit (60+ min)23$3,457$150
Initial hospital care with moderate level of medical decision making at least 75 minutes16$3,082$181
Long return visit (40+ min)11$2,491$100
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes14$2,057$93
New patient visit (60+ min)13$1,954$150

Medicaid work

$9,969 in 2024

Medicaid paid $9,969 for 195 billed services this clinician did in 2024, up to 25 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2024
Long return visit (40+ min)165$9,921
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established)30$48
Medicaid work by year
2024195225$9,969
2023203124$9,746
2022132120$6,279
2021105222$3,759
2020125316$7,328
201915112$954
See the largest Medicaid services in earlier years

2023

Largest Medicaid services in 2023
Long return visit (40+ min)203$9,746

2022

Largest Medicaid services in 2022
Long return visit (40+ min)132$6,279

2021

Largest Medicaid services in 2021
Long return visit (40+ min)65$2,463
SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES40$1,296

2020

Largest Medicaid services in 2020
SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES59$4,889
Return visit (30+ min)54$1,723
Long return visit (40+ min)12$716

2019

Largest Medicaid services in 2019
Long return visit (40+ min)15$954

Drugs they prescribed that Part D paid

$1,538,257

Pharmacies billed $1,538,257 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

295 generic and 147 brand-name prescriptions · $1,538,257 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Xtandi34$483,889$14,232
Inlyta16$330,937$20,684
Nubeqa15$187,517$12,501
Abiraterone Acetate93$154,049$1,656
Orgovyx28$70,814$2,529
See all 11 drugs
Every Part D drug this clinician prescribed
Xtandi34$483,889$14,232
Inlyta16$330,937$20,684
Nubeqa15$187,517$12,501
Abiraterone Acetate93$154,049$1,656
Orgovyx28$70,814$2,529
Myrbetriq24$14,442$602
Eliquis11$6,144$559
Prednisone91$376$4
Ondansetron19$196$10
Prochlorperazine Maleate16$172$11
Dexamethasone12$163$14

Year by year

Part D prescribing by year
202444295None33%$1,538,257
202341185NoneNone$910,768
2022475100NoneNone$768,094
202131773None13%$242,846
20203901073% (13)28%$1,093,004
2019458894% (16)32%$1,532,674
2018327695% (16)36%$1,086,166
20178229None22%$76,631
2015261581% (21)None$1,217

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 8 drugs

Part D drugs prescribed in 2023
Cabometyx13$361,994$27,846
Abiraterone Acetate98$179,584$1,832
Orgovyx40$107,570$2,689
Eliquis15$9,076$605
Myrbetriq12$5,680$473
Prednisone103$792$8
Prochlorperazine Maleate15$167$11
Ondansetron17$127$7

2022: 7 drugs

Part D drugs prescribed in 2022
Abiraterone Acetate102$157,071$1,540
Orgovyx31$80,785$2,606
Prednisone128$1,090$9
Tamsulosin21$560$27
Ondansetron23$319$14
Prochlorperazine Maleate19$225$12
Dexamethasone15$182$12

2021: 8 drugs

Part D drugs prescribed in 2021
Abiraterone Acetate41$57,490$1,402
Eliquis13$7,172$552
Prednisone47$574$12
Ondansetron24$454$19
Dexamethasone17$284$17
Prochlorperazine Maleate18$225$12
Amlodipine Besylate16$58$4
Lorazepam11$52$5

2020: 9 drugs

Part D drugs prescribed in 2020
Xtandi47$510,144$10,854
Zytiga11$120,962$10,997
Abiraterone Acetate11$18,752$1,705
Eliquis13$6,815$524
Prednisone76$562$7
Ondansetron19$294$15
Dexamethasone14$235$17
Prochlorperazine Maleate18$222$12
Tamsulosin12$213$18

2019: 8 drugs

Part D drugs prescribed in 2019
Xtandi56$674,144$12,038
Zytiga58$652,404$11,248
Prednisone117$1,070$9
Ondansetron32$508$16
Dexamethasone20$287$14
Prochlorperazine Maleate17$173$10
Amlodipine Besylate24$91$4
Omeprazole11$69$6

2018: 5 drugs

Part D drugs prescribed in 2018
Zytiga75$768,755$10,250
Xtandi18$204,739$11,374
Prednisone77$651$8
Ondansetron12$134$11
Prochlorperazine Maleate12$67$6

Money from drug and device companies

$575 in 2025

Industry payments by year
2025410None$575
202416$1,992$2,389
202323$825$1,106
202234$2,005$2,132
202111$3,500$3,500
202049$8,650$8,900
2019322$15,700$19,620

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
Dendreon PharmaceuticalsProvenge$269
5 payments
  • Meals for Provenge · 2025-03-28 · $37
  • Meals for Provenge · 2025-03-28 · $72
  • Meals for Provenge · 2025-03-27 · $59
  • Meals for Provenge · 2025-03-27 · $89
  • Meals for Provenge · 2025-03-20 · $13
PfizerXtandi$180
3 payments
  • Meals for Xtandi · 2025-12-19 · $4
  • Meals for Xtandi · 2025-10-29 · $27
  • Meals · 2025-02-14 · $149
AstraZeneca Pharmaceuticals LPLynparza$106
1 payment
  • Meals for Lynparza · 2025-06-12 · $106
ABC Home Medical SupplyNone$20
1 payment
  • Meals · 2025-10-06 · $20
See all 10 published payments
Every published payment
PfizerMeals · 2025-12-19Xtandi$4
PfizerMeals · 2025-10-29Xtandi$27
ABC Home Medical SupplyMeals · 2025-10-06None$20
AstraZeneca Pharmaceuticals LPMeals · 2025-06-12Lynparza$106
Dendreon PharmaceuticalsMeals · 2025-03-28Provenge$37
Dendreon PharmaceuticalsMeals · 2025-03-28Provenge$72
Dendreon PharmaceuticalsMeals · 2025-03-27Provenge$59
Dendreon PharmaceuticalsMeals · 2025-03-27Provenge$89
Dendreon PharmaceuticalsMeals · 2025-03-20Provenge$13
PfizerMeals · 2025-02-14None$149
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)

2024: $2,389

Payments by company in 2024
PfizerPadcev$2,389
6 payments
  • Education for Talzenna · 2024-08-08 · $4
  • Honoraria for Padcev · 2024-06-19 · $1,992
  • Meals · 2024-05-31 · $135
  • Meals for Padcev · 2024-05-31 · $39
  • Meals for Padcev · 2024-05-31 · $71
  • Meals for Inlyta · 2024-01-27 · $148

2023: $1,106

Payments by company in 2023
Janssen Scientific AffairsErleada$825
1 payment
  • Consulting for Erleada · 2023-01-11 · $825
SeagenNone$281
2 payments
  • Meals · 2023-06-05 · $152
  • Meals · 2023-02-17 · $129

2022: $2,132

Payments by company in 2022
PAVmedNone$1,500
2 payments
  • Consulting · 2022-05-30 · $750
  • Consulting · 2022-03-30 · $750
Janssen BiotechErleada$505
1 payment
  • Consulting for Erleada · 2022-12-19 · $505
SeagenNone$127
1 payment
  • Meals · 2022-02-17 · $127

2021: $3,500

Payments by company in 2021
PAVmedNone$3,500
1 payment
  • Consulting · 2021-12-02 · $3,500

2020: $8,900

Payments by company in 2020
Janssen BiotechErleada$3,750
6 payments
  • Paid to speak or teach for Erleada · 2020-07-27 · $500
  • Paid to speak or teach for Erleada · 2020-06-30 · $500
  • Paid to speak or teach for Erleada · 2020-05-26 · $1,000
  • Paid to speak or teach for Erleada · 2020-05-04 · $1,500
  • Meals for Erleada · 2020-02-13 · $125
  • Meals for Erleada · 2020-02-13 · $125
SeagenPadcev$1,840
1 payment
  • Consulting for Padcev · 2020-09-25 · $1,840
Dendreon PharmaceuticalsProvenge$1,750
1 payment
  • Consulting for Provenge · 2020-11-07 · $1,750
Janssen Scientific AffairsErleada$1,560
1 payment
  • Consulting for Erleada · 2020-11-18 · $1,560

2019: $19,620

Payments by company in 2019
Janssen BiotechErleada$19,060
17 payments
  • Paid to speak or teach for Erleada · 2019-12-19 · $500
  • Paid to speak or teach for Erleada · 2019-12-04 · $3,300
  • Meals for Erleada · 2019-11-26 · $15
  • Travel for Erleada · 2019-11-25 · $408
  • Paid to speak or teach for Erleada · 2019-11-20 · $3,300
  • Meals for Erleada · 2019-11-12 · $121
  • Paid to speak or teach for Erleada · 2019-11-01 · $3,800
  • Travel for Erleada · 2019-11-01 · $59
  • Travel for Erleada · 2019-10-27 · $1,111
  • Travel for Erleada · 2019-09-13 · $60
  • Meals for Erleada · 2019-09-13 · $21
  • Paid to speak or teach for Erleada · 2019-09-06 · $3,800
  • Travel for Erleada · 2019-08-29 · $1,396
  • Meals for Erleada · 2019-08-29 · $61
  • Paid to speak or teach for Erleada · 2019-07-22 · $500
  • Meals for Erleada · 2019-07-16 · $108
  • Paid to speak or teach for Erleada · 2019-06-25 · $500
Dendreon PharmaceuticalsProvenge$346
3 payments
  • Meals for Provenge · 2019-12-09 · $124
  • Meals for Provenge · 2019-12-09 · $78
  • Meals for Provenge · 2019-05-20 · $144
Genentech USATecentriq$214
2 payments
  • Meals for Tecentriq · 2019-02-15 · $114
  • Meals · 2019-02-14 · $100

Research money

Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.

Research payments by company and study
Roche Products Limited · Morpheus UC · 2022Their institution$203,064
Roche Products Limited · Morpheus UC · 2023Their institution$150,291
Roche Products Limited · Morpheus UC · 2024Their institution$137,825
Gilead Sciences, Inc. · Stanford Gilead Sciences Digital Health Advisory Board Program · 2023Their institution$83,070
Gilead Sciences, Inc. · Stanford Gilead Sciences Digital Health Advisory Board Program · 2022Their institution$83,070
Roche Products Limited · Morpheus UC · 2025Their institution$34,410
Roche Products Limited · Morpheus UC · 2021Their institution$32,429
Genentech, Inc. · Imcode004 · 2025Their institution$31,309
Roche Products Limited · Morpheus Muc · 2021Their institution$22,086
E.R. Squibb & Sons, L.L.C. · Ph III Mibc Neoadjuvant 1l Bladder Ido Nivo Chemo · 2019Their institution$1,857

Professional record

NPI
1942529227
Licence
CA A120808California A120808: Current · expires 2028-04-30
Trained
University of California, San Francisco School of Medicine, 2013
Video visits
Lists video visits
Gender
Male
More record details
Sole proprietor
No
Taxonomy
Medical oncology (207RX0202X); Federal specialty code 207RH0003X (207RH0003X)
Mailing address
300 Pasteur Dr, Stanford, CA, 94305
NPI first listed
2010-05-25
NPI last updated
2024-04-16
NPI record certified
2024-04-16

This is when the NPI record was last certified, not a medical board exam.

Extra NPI addresses: 993 Twin Brook Dr, San Jose, CA, 95126